Clinical Evaluation of the Nova Max Pro StatSensor Device
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT07392710
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 100 participants
- Registry
-
NCT07392710
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT07392710. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-02-02 (actual); primary completion 2024-12-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Evaluation of the Nova Max Pro StatSensor Device
- Condition
- Kidney Transplant
- Condition
- Kidney Disease, Chronic
- Intervention (Device)
- Nova Max Pro StatSensor device
- Lead sponsor
- Royal Free Hospital NHS Foundation Trust
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct07392710- Content hash
43eb71e7e16b9cee0875ffc032e942f25854555836254b57a0e12b0abe7b44d6